General Information of the Compound
Compound ID
CP0949309
Compound Name
4-(2,4-difluorophenyl)-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine
    Show/Hide
Structure
Formula
C18H19F2N5
Molecular Weight
343.381
Canonical SMILES
Fc1ccc(-c2ncnc3c2cnn3CCN2CCCCC2)c(F)c1
    Show/Hide
InChI
InChI=1S/C18H19F2N5/c19-13-4-5-14(16(20)10-13)17-15-11-23-25(18(15)22-12-21-17)9-8-24-6-2-1-3-7-24/h4-5,10-12H,1-3,6-9H2
    Show/Hide
InChIKey
RZVUGUWNVYBRCQ-UHFFFAOYSA-N
Physicochemical Property
logP
3.2574
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
46.84
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 74767367
ChEMBL ID
CHEMBL4289679
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 93 nM
   TI
   LI
   LO
   TS